Molecular Cancer Research· 2026Q1
Spatial transcriptomic analysis of progressing oral epithelial dysplasia reveals unique differentially expressed genes and microenvironmental changes.
- 0citations
- Q1SCImago
- 2026year
Short summary
Spatial transcriptomics identified unique gene expression and microenvironmental changes during oral epithelial dysplasia (OED) progression to oral squamous cell carcinoma (OSCC), highlighting TNFRSF12A (Fn14) as a potential therapeutic target.
AI-generated from the title and abstract; the full text is not read.
Key points
- Spatial transcriptomics identified differentially expressed genes and microenvironmental changes in progressing OED (OED-P) compared to non-progressing OED (OED-NP).
- Pathway analysis revealed activation of immune, ubiquitination, metabolic reprogramming, and matrix-remodeling signatures during OED progression.
- TNFRSF12A (Fn14) was functionally validated as contributing to OED progression to OSCC.
- The OSCC microenvironment exhibited increased fibroblasts, neutrophils, monocytes, and mast cells compared to OED.
AI-generated from the title and abstract; the full text is not read.
Abstract
Oral squamous cell carcinoma (OSCC) often arises from oral epithelial dysplasia (OED); however, the gene expression changes during OED progression and its microenvironment are not fully understood. This study used spatial transcriptomics to identify differentially expressed genes and microenvironmental alterations associated with malignant transformation of OED. A retrospective analysis of paired OSCC and OED samples was conducted at the Faculty of Dentistry, University of Toronto. A total of 24 paired progressing OED (OED-P) and 23 matched non-progressing OED (OED-NP) cases were examined using spatial transcriptomics in PanCK+ (epithelium) and PanCK- (stroma) regions. The analysis included differential gene expression, pathway analysis, and spatial deconvolution. Our results identified differentially expressed genes in OED-P compared with OED-NP and even more extensive changes between OED-P and matching OSCC. Pathway analysis supported the activation of immune pathways, ubiquitination, metabolic reprogramming, and matrix-remodeling signatures during progression. Functional validation shows that TNFRSF12A (Fn14) contributes to the molecular mechanisms underlying OED progression to OSCC. The OSCC microenvironment showed increased numbers of fibroblasts, neutrophils, monocytes, and mast cells compared with OED. We report a comprehensive transcriptional analysis of matched OED cases, and our results suggest that spatial profiling of OED can help identify unique and actionable gene signatures and microenvironmental changes that occur before oral malignant transformation. Implications: Our study identifies spatially resolved molecular alterations associated with oral cancer development and highlights Fn14 as a promising biomarker and therapeutic target for intercepting malignant transformation.
The authors' abstract, as published at the source. Molecular Cancer Research, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Periodontics
PeriodonticsDentistry